Northern Trust
ARTV

Northern Trust’s Artiva Biotherapeutics ARTV Stock Holding History

Northern Trust’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.6K Buy
+12,208
New +$60.4K ﹤0.01% 4158
2025
Q3 		– Sell
-34,964
Closed -$52.8K – 4555
2025
Q2 		$52.8K Sell
34,964
-106,712
-75% -$224K ﹤0.01% 4223
2025
Q1 		$425K Buy
141,676
+24,564
+21% +$133K ﹤0.01% 3637
2024
Q4 		$1.18M Buy
117,112
+4,335
+4% +$52.1K ﹤0.01% 3316
2024
Q3 		$1.74M Buy
+112,777
New +$1.31M ﹤0.01% 3085

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Northern Trust's ARTV Position: Q1 2026 in Review

Northern Trust opened a new position in Artiva Biotherapeutics (ARTV) in Q1 2026: 12,208 shares worth $78.6K. The stake represents ﹤0.01% of the portfolio and ranks #4158 among its holdings. This is a return to the name: Northern Trust previously reported a position in ARTV as recently as Q2 2025.

Northern Trust first reported a position in ARTV in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.74M in Q3 2024. 40 funds tracked by Wall St. Rank hold ARTV as of Q1 2026.

  • Northern Trust held 12,208 shares of Artiva Biotherapeutics worth $78.6K as of Q1 2026.
  • Artiva Biotherapeutics was a new Northern Trust position in Q1 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4158 holding.
  • Northern Trust first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 5 quarters since.
  • Northern Trust's Artiva Biotherapeutics position peaked at $1.74M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.